ArticleScience translational medicine2017

Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.

Raquel Lima E Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.